Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 572 participants.
Also called NCT01426425
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 572 participants
- Registry
-
NCT01426425
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada
- Registry status
- Completed
Technical summary
Registry record NCT01426425. Allocation not applicable; no masking; primary purpose treatment. Start 2012-05 (registry gives no type); primary completion 2015-09 (actual). Results posted on 2017-03-31.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Intracardiac CrYoablation for AtrioVentricular Nodal Reentrant Tachycardia
- Condition
- AtrioVentricular Nodal Reentrant Tachycardia
- Condition
- Supraventricular Tachycardia
- Condition
- Heart Disease
- Intervention (Device)
- Freezor Xtra Cryoablation Catheter
- Lead sponsor
- Medtronic Cardiac Ablation Solutions
Record details
- Record id
cardio:ct-nct01426425- Content hash
45088ca3df174793f445b4b2e91285deaf1b49a610edcde7f42a28ded4e1dd11